Akari Therapeutics (AKTX) News Today $4.25 +0.26 (+6.52%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 24 at 7:33 AM | msn.comPVL: Okaro switches to ‘destroy mode’ for AkariJuly 23 at 9:29 PM | msn.comPVL: Oly Okaro, Akari send Choco Mucho to 0-2 startJuly 22, 2024 | americanbankingnews.comAkari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.comJuly 19, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Trend Lower Friday; Set to End Week Down 4%May 16, 2024 | finance.yahoo.comAkari Therapeutics Reports First Quarter 2024 Financial Results and Recent HighlightsMay 16, 2024 | globenewswire.comAkari Therapeutics Reports First Quarter 2024 Financial Results and Recent HighlightsMay 2, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday TradingMay 1, 2024 | msn.comAkari gains despite leadership change amid portfolio shakeupMay 1, 2024 | markets.businessinsider.comAkari Therapeutics Appoints Samir Patel Interim CEO After CEO Rachelle Jacques Steps DownMay 1, 2024 | globenewswire.comSamir R. Patel, M.D. Appointed Interim CEO for Akari TherapeuticsMay 1, 2024 | globenewswire.comAkari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger EntityApril 15, 2024 | finanznachrichten.deAkari Therapeutics Plc: Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024April 15, 2024 | globenewswire.comAkari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024April 12, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Lower in Friday TradingApril 12, 2024 | msn.comDindin lethal in Akari’s disposal of Capital1April 1, 2024 | finance.yahoo.comAkari Therapeutics Insider Ups Holding By 69% During YearApril 1, 2024 | globenewswire.comAkari Therapeutics Reports Full-Year 2023 Financial Results and Recent HighlightsMarch 17, 2024 | msn.comPVL: Fifi Sharma, Ced Domingo power Akari romp of NxledMarch 7, 2024 | bizjournals.comPetri Dish: C4’s deal with Merck KGaA; Boston and California biotechs mergeMarch 6, 2024 | stockhouse.comSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AKTX, HES, TGAN, NSMarch 5, 2024 | businesswire.comAKTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Akari Therapeutics, Plc Is Fair to ShareholdersFebruary 27, 2024 | msn.comPVL: Grethcel Soltones, Akari still a work in progressFebruary 25, 2024 | msn.comPVL: Ced Domingo has a quiet Akari debut as she adjusts to new systemFebruary 24, 2024 | msn.comPVL: Cignal turns back Akari to open All-Filipino bidFebruary 16, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Set to End Week Higher in Friday TradingFebruary 9, 2024 | msn.comPVL: Akari’s Max Juangco taking pressure of her pro debut in strideFebruary 7, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Slightly Lower in Wednesday TradingFebruary 2, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Trend Lower in Friday Trading But End Week HigherJanuary 23, 2024 | investing.comAkari Therapeutics PLC (AKTX)January 22, 2024 | msn.comPVL: Faith Nisperos, Akari Chargers aim for Final FourJanuary 2, 2024 | finanznachrichten.deAkari Therapeutics Plc: Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement FinancingJanuary 2, 2024 | finance.yahoo.comAkari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement FinancingJanuary 2, 2024 | finance.yahoo.comAkari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement FinancingDecember 16, 2023 | msn.comAkari Therapeutics Plc - ADR (AKTX) Price Target Increased by 45.45% to 81.60December 14, 2023 | finance.yahoo.comAkari Therapeutics to Present at Biotech Showcase 2024December 2, 2023 | investing.comAkari Therapeutics (AKTX) Earnings Dates & ReportsDecember 1, 2023 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Poised to End Week Flat in Friday TradingNovember 28, 2023 | sg.finance.yahoo.comAkari Therapeutics, Plc (CLA.F)November 24, 2023 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Climb Higher FridayNovember 16, 2023 | finance.yahoo.comAkari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development ConferenceNovember 14, 2023 | msn.comTravel, Pharma Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher TuesdayNovember 6, 2023 | finance.yahoo.comAkari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development ConferenceOctober 3, 2023 | finance.yahoo.comPresenting on the Emerging Growth Conference 63 Day 1 on October 4 Register NowSeptember 29, 2023 | finanznachrichten.deAkari Therapeutics Plc: Akari Therapeutics Reports First Half 2023 Financial Results and HighlightsSeptember 29, 2023 | finance.yahoo.comAkari Therapeutics Reports First Half 2023 Financial Results and HighlightsSeptember 27, 2023 | finance.yahoo.comAkari Therapeutics to Present at Emerging Growth ConferenceSeptember 21, 2023 | finance.yahoo.comAkari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing, Company Also Receives $2.5 Million U.K. R&D Tax CreditSeptember 19, 2023 | finance.yahoo.comAkari Therapeutics to Host Key Opinion Leader Webinar on Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) and the Potential of Nomacopan to Address Significant Unmet NeedsSeptember 5, 2023 | finance.yahoo.comAkari Therapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementAugust 31, 2023 | msn.comAkari Therapeutics Plc - ADR (AKTX) Price Target Increased by 1900.00% to 56.10 Get Akari Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address “Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event. You can find out what they are by clicking here now. AKTX Media Mentions By Week AKTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKTX News Sentiment▼0.150.61▲Average Medical News Sentiment AKTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKTX Articles This Week▼61▲AKTX Articles Average Week Get Akari Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cocrystal Pharma News Today Oncternal Therapeutics News Today Regulus Therapeutics News Today Adagene News Today Relmada Therapeutics News Today FibroGen News Today Coya Therapeutics News Today Sagimet Biosciences News Today InterCure News Today Adicet Bio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKTX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics, Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Akari Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.